About this trial
The purpose of this study is to compare two approaches for monitoring pancreatic cysts as well as to identify associated biomarkers. The study doctors want to compare more frequent monitoring versus less frequent monitoring as well as identify biomarkers which may improve risk detection of transformation to pancreatic cancer. The study doctors want to learn which monitoring method and which biomarkers lead to better outcomes for patients.
Eligibility criteria
Qualifiers
Patient must be ≥ 50 years and ≤ 75 years of age
Patient must not have acute pancreatitis or a history of chronic pancreatitis
Patient must have received a CT, MRI, or EUS within 6 months prior to enrollment that revealed one or more ≥ 1 cm pancreatic cyst(s).
Patients of childbearing potential must not be known to be pregnant
Disqualifiers
None
Trial design
Treatments tested in this trial
- Biopsy Procedure
- Biospecimen Collection
- Computed Tomography
- Endoscopic Ultrasound
- Endoscopic Ultrasound-Guided Fine-Needle Aspiration
- Magnetic Resonance Imaging
- Quality-of-Life Assessment
- Questionnaire Administration
- Surgical Procedure
Treatment groups
Sponsors and collaborators
ECOG-ACRIN Cancer Research Group
Lead sponsor
National Cancer Institute (NCI)
Collaborator